Literature DB >> 68375

Coxsackie B neutralisation titres in polymyositis/dermatomyositis.

R L Travers, G R Hughes, G Cambridge, J R Sewell.   

Abstract

Entities:  

Mesh:

Year:  1977        PMID: 68375     DOI: 10.1016/s0140-6736(77)92487-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  15 in total

Review 1.  Polymyositis-dermatomyositis: a clinical review.

Authors:  K W Strauss; H Gonzalez-Buritica; M A Khamashta; G R Hughes
Journal:  Postgrad Med J       Date:  1989-07       Impact factor: 2.401

Review 2.  Immunological features of polymyositis/dermatomyositis.

Authors:  W M Behan; P O Behan
Journal:  Springer Semin Immunopathol       Date:  1985

Review 3.  Sporadic viral myositis in two adults.

Authors:  C D Naylor; A M Jevnikar; N J Witt
Journal:  CMAJ       Date:  1987-11-01       Impact factor: 8.262

4.  Origin and regulation of a disease-specific autoantibody response. Antigenic epitopes, spectrotype stability, and isotype restriction of anti-Jo-1 autoantibodies.

Authors:  F W Miller; S A Twitty; T Biswas; P H Plotz
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

5.  Coxsackie B infection and arthritis.

Authors:  N P Hurst; A G Martynoga; G Nuki; J R Sewell; A Mitchell; G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-19

6.  Autoantibodies in lupus and its variants: experience in 1000 patients.

Authors:  G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1984-08-11

7.  Acute dermatomyositis associated with a staphylococcal infection.

Authors:  A M Haegerty; N P Byrom; J B Cookson
Journal:  Postgrad Med J       Date:  1981-12       Impact factor: 2.401

8.  Familial canine dermatomyositis. Initial characterization of the cutaneous and muscular lesions.

Authors:  A M Hargis; K H Haupt; G A Hegreberg; D J Prieur; M P Moore
Journal:  Am J Pathol       Date:  1984-08       Impact factor: 4.307

9.  Polymyositis and dermatomyositis: no persistence of enterovirus or encephalomyocarditis virus RNA in muscle.

Authors:  P J Jongen; G J Zoll; M Beaumont; W J Melchers; L B van de Putte; J M Galama
Journal:  Ann Rheum Dis       Date:  1993-08       Impact factor: 19.103

10.  Viral persistence during the developmental phase of Coxsackievirus B1-induced murine polymyositis.

Authors:  P E Tam; A M Schmidt; S R Ytterberg; R P Messner
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.